Skip to main content
  1. Right Decisions
  2. Neurology pathways
  3. Back
  4. Headache
  5. 1. National Headache Pathway
Announcements and latest updates

Right Decision Service newsletter: September 2024

Welcome to the Right Decision Service (RDS) newsletter for September 2024.

1.Business case for permanent provision of the Right Decision Service from April 2025 onwards

This business case has now been endorsed by the HIS Board and will shortly be submitted to Scottish Government.

2. Management of RDS support tickets

To balance increasing demand with available capacity and financial resource, the RDS team and Tactuum are now working together to  implement closer management of support tickets. As a key part of this, we want to ensure clear, timely and consistent communication with yourselves as requesters.  

Editors will now start seeing new messages come through in response to support ticket requests which reflect this tightening up and improvement of our processes.

Key points to note are:

2.1 Issues confirmed by the RDS and Tactuum teams as meeting the critical/urgent and high priority criteria will continue to be prioritised and dealt with immediately.

Critical/urgent issues are defined as:

  1. The Service as a whole is not operational for multiple users. OR
  2. Multiple core functions of the Service are not operational for multiple users.

Example – RDS website outage.

Please remember to email ann.wales3@nhs.scot and his.decisionsupport@nhs.scot with any critical/urgent issues in addition to raising a support ticket.

High priority issues are defined as:

  1. A single core function of the Service is not operational for multiple users. OR:
  2. Multiple non-core functions of the Service are not operational for multiple users.

Example – Build to app not working.

2.2 Support requests that are outwith the warranty period of 12 weeks since the software was originally developed will not be automatically addressed by Tactuum. The RDS team will consider these requests for costed development work and will obtain estimate of effort and cost from Tactuum for priority issues.

2.3 Support tickets for technical issues that are not classified as bugs will not be automatically addressed by Tactuum. The definition of a bug is ‘a defect in the software that is at variance with documented user requirements.’  Issues that are not bugs will also be considered for costed development work.

The majority of issues currently in support tickets fall into category 2 or 3 above, or both.

2.4 Non-urgent requests that require a deployment (i.e a new release of RDS) will normally be factored into the next scheduled release (currently end of Nov 2024 and end of Feb 2025) unless by special agreement with the RDS team.

Please note that we plan to move in the new year to a new system whereby requests all come to an RDS support portal in the first instance and are triaged from there to Tactuum when appropriate.

We will be organising a webinar in a few weeks’ time to take you through the details of the current support processes and criteria.

3. Next scheduled deployment.

The next scheduled RDS deployment will take place at the end of November 2024.  We are reviewing all outstanding support tickets and feature requests along with estimates of effort and cost to determine which items will be included in this deployment.

We will update you on this in the next newsletter and in the planned webinar about support ticket processes.

4. Contingency arrangements for RDS

Many thanks to those of you who attended our recent webinar on the contingency arrangements being put in place to prevent future RDS outages as far as possible and minimise impact if they do occur.  Please contact ann.wales3@nhs.scot if you would like a copy of the slides from this session.

5. Transfer of CKP pathways to RDS

The NES clinical knowledge pathway (CKP) publisher is now retired and the majority of pathways supported by this tool have been transferred to the RDS. Examples include:

NHS Lothian musculoskeletal pathways

NHS Fife rehabilitation musculoskeletal pathways

NHS Tayside paediatric pathways

6. Other new RDS toolkits

Include:

Focus on frailty (from HIS Frailty improvement programme)

NHS GGC Money advice and support

If you would like to promote one of your new toolkits through this newsletter, please contact ann.wales3@nhs.scot

To go live imminently:

  • Focus on dementia
  • NHS Lothian infectious diseases toolkit
  • Dumfries and Galloway Adult Support and Protection procedures
  • SIGN guideline – Prevention and remission of type 2 diabetes

 

7. Evaluation projects

We have recently analysed the results of a survey of users of the Scottish Palliative Care Guidelines toolkit.  Key findings from 61 respondents include:

  • Most respondents (64%) are frequent users of the toolkit, using it either daily or weekly. A further 25% use it once or twice per month.
  • 5% of respondents use the toolkit to deliver direct patient care and 82% use it for learning
  • Impact on practice and decision-making was rated as very high, with 80% of respondents rating these at a 4-5 on a 5 point scale.
  • Impact on time saving was also high, with 74% of respondents rating it from 3-5.
  • 74% also reported that the toolkit improved their knowledge and skills, rating these at 4-5 on the Likert scale

Key strengths identified included:

  • The information is useful, succinct, and easy to understand (31%).
  • Coverage is comprehensive (15%)
  • All information is readily accessible in one place and users value the offline access via mobile app (15%)
  • Information is reliable, evidence-based and up to date (13%)

Users highlighted key areas for improvement in terms of navigation and search functionality. The survey was very valuable in enabling us to uncover the specific issues affecting the user experience. Many of these can be addressed through content management approaches. The issues identified with search results echo other user feedback, and we are costing improvements with a view to implementation in the next RDS deployment.

8.RDS High risk prescribing (polypharmacy) decision support embedded in Vision and EMIS primary care E H R systems

This decision support software, sponsored by Scottish Government Effective Prescribing and Therapeutics Division,  is now available for all primary care clinicians across NHS Tayside. Board-wide implementation is also planned for NHS Lothian, and NHS GGC, NHS Ayrshire and Arran and NHS Dumfries and Galloway have initial pilots in progress. The University of Dundee has been commissioned to evaluate impact of this decision support software on prescribing practice.

9. Video tutorials for RDS editors

Ten bite-size (5 mins or less) video tutorials for RDS editors are now available in the “Resources for providers of RDS tools” section of the RDS.  These cover core functionality including Save and preview, content page and media management, password management and much more.

10. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Wednesday 23rd October 4-5 pm
  • Tuesday 29th October 11 am -12 pm

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

 

Warning

Background

The following diagram gives an overview of the primary care pathway (through to the interface with secondary care) based on presentation at General Practice. 

National Headache Pathway Builder

Pathway Recommendations

Most patients presenting to health services with headaches have primary headache (up to 95% presenting to primary care and over 50% presenting to A&E). The most common primary headache is migraine, making up the majority of these patients. Most patients with migraine can be adequately managed in primary care. Some patients, particularly those with more frequent headache may need input from secondary care.

The following diagram lists the important red, amber and green flags:

RED FLAGS

Most patients do not have serious secondary headache. Red flags indicate the need for urgent
assessment to exclude a secondary cause. The most consistent indicators for serious secondary
causes for headache are:


1) Thunderclap (sudden onset) headache (consider SAH and its differential)
2) New focal neurological deficit on examination (e.g. hemiparesis)
3) Systemic features (considering GCA, infection such as meningitis or encephalitis, etc)
4) New progressive headache in a patient over 50 (most headaches presenting in patients
over 50 are benign, but there is an increased risk of secondary pathology with
increasing age)

Thunderclap headache is usually occipital or global. It is defined as a severe abrupt onset
headache, usually reaching its peak instantaneously, but headache can progress over up to 5
minutes. The main consideration is subarachnoid haemorrhage, but other causes include cervical
artery dissection, intracranial haemorrhage, posterior circulation stroke, cerebral venous sinus
thrombosis and spontaneous intracranial hypotension. Anyone presenting with a thunderclap
headache should have a same day referral (which may be through A&E), even in delayed
presentations.

A new focal neurological symptom (eg seizure) or sign (eg hemiparesis) in a patient with a new
progressive headache indicates the possibility of an intracranial pathology and this should prompt
an urgent referral for assessment and appropriate imaging. The referring clinical should decide
whether this merits attendance at A&E, a call to the appropriate specialist service or an urgent
referral. Specific syndromes that may indicate the possibility of a brain tumour are listed below, but
extra dural / sub dural haematomas, cerebral venous sinus thrombosis, viral encephalitis and
other intracranial pathology can present similarly.


Headache suggesting the possibility of a brain tumour
1) New headache plus sub-acute progressive focal neurology
2) New headache plus seizures
3) New headache with personality or cognitive change not suggestive of dementia, with no
psychiatric history and confirmed by witness

Fever, neck stiffness and rash should raise the consideration of infection such as meningitis and
constitutional symptoms and scalp tenderness should raise the consideration of Giant Cell Arteritis
(GCA).

Most headache in older patients will have a benign cause (mainly migraine), but the clinician
should have a lower threshold for considering a secondary cause in an older patient with a new
persisting or worsening headache. Anyone over 50 with a new headache should have a CRP +/-
plasma viscosity +/- ESR + FBC as per local protocol to consider GCA. Anyone where this is a
serious consideration should have an urgent referral and consideration of steroids as per local
protocol.

AMBER FLAGS 

Features that may indicate a secondary cause but may also be seen in primary headaches:
1) Changes in headache intensity with changes of posture (upright consider low pressure /
headache when lying flat consider high pressure)
2) Worsening/Triggering headache with Valsalva (e.g. coughing, straining)
3) Atypical aura (duration >1 hour or including motor weakness)
4) Progressive headache (worsening over weeks or longer)
5) Head trauma within the last month
6) Previous history of cancer or HIV
7) Re-attendance to A&E or GP surgery with progressively worsening headache severity or
frequency

Consider a secondary cause if any of these are present.

Orthostatic headache should have a consistent onset / worsening on assuming an upright posture
and offset / significant improvement on lying flat. This should be differentiated from headache
which improves on lying still, which is a feature of migraine. Early assessment and treatment of
Spontaneous Intracranial Hypotension (SIH) improves outcomes and patients with orthostatic
headache should be referred urgently. Further information is available in the consensus guidelines
on SIH.

 

Headache wakening the patient, headache present on wakening which then improves after
assuming an upright posture and Valsalva headache (headache triggered by coughing or other
Valsalva manoeuvres) raises the possibility of raised intracranial pressure. Headache present on
wakening which improves after assuming an upright posture may also be due to cervicogenic
headache and obstructive sleep apnoea or other causes of nocturnal hypoventilation. Migraine
starting in sleep is the commonest cause for wakening with a headache (especially if the
headache is intermittent). It is also important to consider Medication Overuse Headache as
“wearing off” of the overused medication during sleep can result in wakening with a headache
which then improves with taking the overused medication. These patients are likely to have
migraine.


Normal imaging does not exclude raised intracranial pressure and it is important to examine the
patient for papilloedema. An urgent optician assessment should be considered where the clinician
is not confident undertaking ophthalmoscopy. More detail on the assessment and management of
Intracranial Hypertension can be found on (insert link). Due to risk to vision, patients should be
referred same day as per local protocol, usually to ophthalmology in the first instance.


A history of cancer, immunosuppression (including HIV) and recent head trauma in a patient with
new progressive headache should raise the consideration of secondary brain tumour, infection or
intracranial haemorrhage. These patients usually have other features in addition to headache.

Features that do not help to differentiate primary from secondary headaches are:
1) Severity
2) Treatment response

GREEN FLAGS 

Features that are supportive of a diagnosis of primary headache:
1) Recurrent episodic headache, particularly with features of migraine
2) Long history of daily headache

If there are no concerning features then it is appropriate to manage these patients for migraine.

Other features that are pointers to migraine include a previous migraine history and a family
history of migraine.

Diagnosis of primary headache syndromes

Migraine is the commonest primary headache presenting to both primary and secondary care. It is however important to consider other primary headache disorders as per the following table. 

Headache feature  Migraine (with or without aura)  Cluster headache  Tension-type headache 
Frequency  Majority of patients presenting to both primary and secondary care (94% of people presenting in primary care with episodic headache will have migraine)  Rare - 1 in 1,000  Very common, but not  often seen in primary or secondary care as usually mild and self-managed 
Duration of headache 

4 – 72 hours in adults 

1 – 72 hours in young people 

15 minutes to 3 hours  30 minutes – continuous 
Pain location 

Unilateral or bilateral 

(head, face or neck) 

Unilateral (around the eye, above the eye and along the side of the head/face) 

Bilateral 

(head, face or neck) 

Pain quality 

Pulsating 

(throbbing or banging in young people) 

Variable (can be sharp, boring, burning, throbbing or tightening) 

Pressing/tightening 

(non-pulsating) 

Pain intensity  Moderate or severe  Severe or very severe  Mild or moderate 
Effect of activities 

Aggravated by, or causes avoidance of, routine activities of daily living 

(e.g. prefer to stay still or go to bed) 

Restlessness or agitation  Not aggravated by routine activities of daily living 
Other symptoms 
  • Photophobia (sensitivity to light) 
  • Phonophobia (sensitivity to sound) 
  • Nausea and/or vomiting 
  • Allodynia (sensitivity to touch) 
  • Cranial autonomic symptoms 
  • Aura (lasts 5 – 60 minutes) can include: 
  • Flickering lights, spots or lines and/or partial loss of vision 
  • Sensory symptoms such as numbness and/or pins and needles 
  • Speech disturbance 

Cranial autonomic symptoms on the same side as the headache: 

  • Red and/or watery eye 
  • Nasal congestion and/or runny nose 
  • Swollen eyelid 
  • Forehead and facial sweating 
  • Constricted pupil and/or drooping eyelid 

Patients with cluster can get migrainous symptoms and aura 

None 

Please note that this table may require scrolling to view all content.

Migraine is differentiated into episodic and chronic migraine 

Patients with episodic have migraine on 14 or less days per month (high frequency episodic migraine 10-14 days per month). 

Patients with chronic migraine have 15 or more days of headache per month 8 of which should meet criteria for migraine. Chronic migraine therefore usually presents with a mixture of milder background headache and migraine. 

Information to help with diagnosis of headache

  • Patients with migraines often underplay their symptoms 
  • Recurrent ‘sinus headache’ and/or dizziness is usually migraine 
  • In patients with chronic migraine, there is usually background headache with superimposed migraine days 
  • In patients taking acute treatment on >10 days/month, consider medication overuse headache 
  • Most patients waking with headache have migraine or medication overuse headache (withdrawal of overused analgesia overnight) 
  • Menstrual headache is almost always migraine and migraine usually improves in pregnancy 
  • Most patients with migraine are sensitive to head movement during a migraine so bending, coughing or sneezing during a migraine may make headache worse (motion sensitivity) 
  • Most patients with migraine don't have aura  
  • 40% of migraine is bilateral 

Referral to secondary care (migraine)

Migraine is the most likely diagnosis for a patient attending primary care with headache. Many of these patients will be successfully managed in primary care. If there is a clear diagnosis of migraine we recommend acute +/- preventative treatment (as detailed in the acute and preventative treatment sections).  

Where preventative treatment is not successful after a trial of three preventative medications at an adequate dose and for an adequate length of time, consider referral to relevant secondary care services as per local arrangements.

If there is diagnostic uncertainty or concern about a secondary cause, consider open access CT as an alternative to secondary care referral. 

Patient lifestyle advice for migraine

Patients should be directed to the resources available on NHS Inform to for lifestyle advice. Where consultation time allows the following key points should be made in relation to lifestyle. 

  1. Regular sleep pattern. 
  2. Regular eating pattern / don’t skip meals (more frequent small meals may help). 
  3. Regular fluid intake but limit alcohol, and limit caffeine from tea, coffee and some soft drinks. 
  4. Regular physical activity/exercise 
  5. Regular breaks from computers/phone screens  
  6. Relaxation activities such as mindfulness, yoga or meditation 

Manage potential triggers as needed; e.g. avoid perfumes, certain food triggers if applicable, bright, flashing or flickering lights (consider wearing sunglasses when outside or in bright, flashing or flickering light) 

Further advice is available from the Migraine Trust on 0808 802 0066 or https://migrainetrust.org/what-we-do/our-information-and-support-service/ 

References and further resources

SIGN 155 Clinician Guidance:  

SIGN 155 Pharmacological management of migraine 2023 update 

SIGN 155 patient guidance: 

SIGN Migraine patient booklet PAT155 (revised 2022) 

Heads up podcasts from the National Migraine Centre: 

Heads Up podcast - National Migraine Centre 

British Association for the Study of Headache - Headache management system 

Headache UK Optimal clinical pathway for adults with headache and facial pain. NNAG (National Neurosciences Advisory Group). 2023.

Optimal clinical pathway for adults with headache and facial pain — National Neurosciences Advisory Group (nnag.org.uk) 

Mollan S. et al. Evaluation and Management of adult idiopathic intracranial hypertension. Practical Neurology. 2018. Evaluation and management of adult idiopathic intracranial hypertension (bmj.com) 

Cheema S. et al. Multidisciplinary consensus guideline for the diagnosis and management of spontaneous intracranial hypotension. JNNP. 2023. https://jnnp.bmj.com/content/early/2023/05/04/jnnp-2023-331166 

Editorial Information

Last reviewed: 11/10/2023

Next review date: 01/04/2025